You're thinking of participating in a clinical trial – what now? Ask questions and weigh the risks before deciding if a clinical trial is right for you.

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Today, adoption of digital health faces some of the same barriers — scepticism, budget limitations, high expectations, and a ...

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

The drug is currently approved in 12 mg doses. The high-dose applications are based on results from the phase 2/3 Devote trial ... treated with Omvoh achieved clinical remission after a year ...

Researchers at Johns Hopkins Medicine have discovered that a drug originally developed for Alzheimer’s disease, schizophrenia ...

The 5 mg risdiplam tablet provides the same efficacy and safety for spinal muscular atrophy as the currently available oral ...

In the Phase 2 open-label Oral Anaphylm Symptom Intervention Study ("OASIS”) study, adults with Oral Allergy Syndrome (n=36) received Anaphylm under different conditions, including single and repeat ...